Published in Neurology on June 01, 1996
Protective actions of sex steroid hormones in Alzheimer's disease. Front Neuroendocrinol (2009) 1.71
Effects of family history and apolipoprotein E epsilon4 status on cognitive decline in the absence of Alzheimer dementia: the Cache County Study. Arch Neurol (2009) 1.63
Reduced hippocampal activation during episodic encoding in middle-aged individuals at genetic risk of Alzheimer's disease: a cross-sectional study. BMC Med (2006) 1.42
Reduced gray matter volume in normal adults with a maternal family history of Alzheimer disease. Neurology (2010) 1.41
Progressive regional atrophy in normal adults with a maternal history of Alzheimer disease. Neurology (2011) 1.23
Maternal transmission of Alzheimer's disease: prodromal metabolic phenotype and the search for genes. Hum Genomics (2010) 1.12
Amyloid and metabolic positron emission tomography imaging of cognitively normal adults with Alzheimer's parents. Neurobiol Aging (2012) 0.96
The behavioural/dysexecutive variant of Alzheimer's disease: clinical, neuroimaging and pathological features. Brain (2015) 0.94
Factors affecting the age of onset and rate of progression of Alzheimer's disease. J Neurol Neurosurg Psychiatry (1998) 0.93
A prospective study of cognitive health in the elderly (Oregon Brain Aging Study): effects of family history and apolipoprotein E genotype. Am J Hum Genet (1997) 0.93
The relevance of beta-amyloid on markers of Alzheimer's disease in clinically normal individuals and factors that influence these associations. Neuropsychol Rev (2014) 0.86
Association of COMT val158met and DRD2 G>T genetic polymorphisms with individual differences in motor learning and performance in female young adults. J Neurophysiol (2013) 0.84
Family history of dementia predicts worse neuropsychological functioning among HIV-infected persons. J Neuropsychiatry Clin Neurosci (2011) 0.81
BuChE K variant is decreased in Alzheimer's disease not in fronto-temporal dementia. J Neural Transm (Vienna) (2010) 0.81
Butyrylcholinesterase K variant is genetically associated with late onset Alzheimer's disease in Northern Ireland. J Med Genet (2000) 0.80
Apolipoprotein E, angiotensin-converting enzyme and kallikrein gene polymorphisms and the risk of Alzheimer's disease and vascular dementia. J Neural Transm (Vienna) (2006) 0.79
Which neuropsychological tests predict progression to Alzheimer's disease in Hispanics? Neuropsychology (2013) 0.76
Risk of dementia in parents of probands with and without the apolipoprotein E4 allele. The EVA study. J Epidemiol Community Health (1999) 0.75
Germline E-cadherin mutations in hereditary diffuse gastric cancer: assessment of 42 new families and review of genetic screening criteria. J Med Genet (2004) 2.95
Mild cognitive impairment: directions for future research. Neurology (2003) 1.78
Medial temporal lobe atrophy on MRI scans and the diagnosis of Alzheimer disease. Neurology (2008) 1.74
Biological impact on mineral dissolution: application of the lichen model to understanding mineral weathering in the rhizosphere. Proc Natl Acad Sci U S A (1999) 1.72
Neural-network classification of normal and Alzheimer's disease subjects using high-resolution and low-resolution PET cameras. J Nucl Med (1994) 1.66
Cognition in early human immunodeficiency virus infection. Arch Neurol (1990) 1.59
Induction of depressive affect after prolonged exposure to a mildly depressed individual. J Pers Soc Psychol (1985) 1.46
Cerebral ventricles are smaller in Hispanic than non-Hispanic patients with Alzheimer's disease. Neurology (2000) 1.45
Category fluency test: normative data for English- and Spanish-speaking elderly. J Int Neuropsychol Soc (2000) 1.32
H2O2 acts on cellular membranes to generate ceramide signaling and initiate apoptosis in tracheobronchial epithelial cells. J Cell Sci (1998) 1.31
A comparative analysis of neuropsychological test performance of Spanish-speaking and English-speaking patients with Alzheimer's disease. J Gerontol (1993) 1.25
Sensitivity and specificity of three clinical criteria for dementia with Lewy bodies in an autopsy-verified sample. Int J Geriatr Psychiatry (1999) 1.11
Phonological agraphia: writing by the lexical-semantic route. Neurology (1983) 1.09
Depressive symptomatology in first-degree family caregivers of Alzheimer disease patients: a cross-ethnic comparison. Alzheimer Dis Assoc Disord (1998) 1.09
Relationship of behavioral and psychological symptoms to cognitive impairment and functional status in Alzheimer's disease. Int J Geriatr Psychiatry (2000) 1.07
Sensitivity of cerebral glucose metabolism to age, gender, brain volume, brain atrophy, and cerebrovascular risk factors. J Cereb Blood Flow Metab (1988) 1.04
Caregivers' judgments of the functional abilities of the Alzheimer's disease patient: impact of caregivers' depression and perceived burden. J Geriatr Psychiatry Neurol (2001) 1.04
Association of white matter hyperintensity measurements on brain MR imaging with cognitive status, medial temporal atrophy, and cardiovascular risk factors. AJNR Am J Neuroradiol (2009) 1.02
Utility of a modified Mini-Mental State Examination with extended delayed recall in screening for mild cognitive impairment and dementia among community dwelling elders. Int J Geriatr Psychiatry (2000) 1.02
Evaluation of a neural-network classifier for PET scans of normal and Alzheimer's disease subjects. J Nucl Med (1992) 0.99
Neuroanatomic differences between dyslexic and normal readers on magnetic resonance imaging scans. Arch Neurol (1991) 0.99
MR signal abnormalities in memory disorder and dementia. AJNR Am J Neuroradiol (1990) 0.99
A comparison of familial and sporadic Alzheimer's disease. Neurology (1993) 0.97
Cerebral metabolic effects of a verbal fluency test: a PET scan study. J Clin Exp Neuropsychol (1988) 0.94
Predictors of positive and negative appraisal among Cuban American caregivers of Alzheimer's disease patients. Int J Geriatr Psychiatry (2000) 0.93
A cross-ethnic analysis of risk factors for AD in white Hispanics and white non-Hispanics. Neurology (1999) 0.92
Apolipoprotein-E (APO-E) genotype and symptoms of psychosis in Alzheimer's disease. Am J Geriatr Psychiatry (1999) 0.92
Positron emission tomographic studies during serial word-reading by normal and dyslexic adults. J Clin Exp Neuropsychol (1991) 0.90
Prevalence and correlates of Capgras syndrome in Alzheimer's disease. Int J Geriatr Psychiatry (1999) 0.87
Predominant left hemisphere metabolic dysfunction in dementia. Arch Neurol (1989) 0.86
Predictors of anxiety in patients with Alzheimer's disease. Depress Anxiety (2000) 0.85
Behavioral activation and the variability of cerebral glucose metabolic measurements. J Cereb Blood Flow Metab (1987) 0.84
Family history as a predictor of uptake of cancer preventive procedures by women with a BRCA1 or BRCA2 mutation. Clin Genet (2008) 0.83
Metabolic asymmetries in asymptomatic HIV-1 seropositive subjects: relationship to disease onset and MRI findings. J Nucl Med (1991) 0.83
Increases in both cerebral glucose utilization and blood flow during execution of a somatosensory task. Ann Neurol (1988) 0.83
Factors associated with the initiation of breast-feeding by Aboriginal mothers in Perth. Public Health Nutr (2004) 0.83
A qualitative analysis of semantic intrusive errors in Alzheimer's disease. Arch Clin Neuropsychol (1995) 0.82
Human task-specific somatosensory activation. Neurology (1987) 0.82
The factor structure of the Cornell Scale for Depression in Dementia among probable Alzheimer's disease patients. Am J Geriatr Psychiatry (1998) 0.82
MR signal abnormalities in memory disorder and dementia. AJR Am J Roentgenol (1990) 0.81
The genetic association between Cathepsin D and Alzheimer's disease. Neurosci Lett (2000) 0.81
The behavioral pathology in Alzheimer's Disease Scale (BEHAVE-AD): factor structure among community-dwelling Alzheimer's disease patients. Int J Geriatr Psychiatry (1998) 0.81
Viability of neocortical function shown in behavioral activation state PET studies in Alzheimer disease. J Cereb Blood Flow Metab (1992) 0.80
Association between Alzheimer's disease and a functional polymorphism in the Myeloperoxidase gene. Exp Neurol (2001) 0.80
Familial and population-based studies of apolipoprotein E and Alzheimer's disease. Ann N Y Acad Sci (1996) 0.79
Asymmetric somatosensory activation with right- vs left-hand stimulation: a positron emission tomographic study. Brain Res (1989) 0.79
Factors associated with depressive symptoms in non-demented community-dwelling elderly. Int J Geriatr Psychiatry (1999) 0.78
Brain-reactive antibodies and the AIDS dementia complex. J Acquir Immune Defic Syndr (1989) 0.78
Pure Gerstmann's syndrome from a focal lesion. Arch Neurol (1983) 0.78
Positional dyslexia. Brain Lang (1989) 0.77
Depressive symptoms in Alzheimer's disease. An examination among community-dwelling Cuban American patients. Am J Geriatr Psychiatry (2000) 0.76
Peripheral serotonin in Alzheimer's disease. Neuropsychobiology (1995) 0.76
Structural changes in the vestibular epithelia in elderly monkeys and humans. Adv Otorhinolaryngol (1977) 0.76
Clinical characteristics of community-dwelling black Alzheimer's disease patients. J Natl Med Assoc (2000) 0.76
No association between the intronic presenilin-1 polymorphism and Alzheimer's disease in clinic and population-based samples. Am J Med Genet (1997) 0.75
Cerebrocerebellar relationship during behavioral activation: a PET study. J Cereb Blood Flow Metab (1991) 0.75
Association between premorbid history of depression and current depression in Alzheimer's disease. J Geriatr Psychiatry Neurol (1999) 0.75
Hereditary colorectal cancer registries in Canada: report from the Colorectal Cancer Association of Canada consensus meeting; Montreal, Quebec; October 28, 2011. Curr Oncol (2013) 0.75
Serotonin uptake and its kinetics in platelets of women with Alzheimer's disease. Psychiatry Res (1995) 0.75
Screening for multiple endocrine neoplasia type 2A with DNA-polymorphism analysis. Henry Ford Hosp Med J (1992) 0.75
Basic office testing of mental status in the elderly. Geriatrics (1982) 0.75
Interfamilial and intrafamilial phenotypic heterogeneity in familial Alzheimer's disease. J Geriatr Psychiatry Neurol (1997) 0.75
The Behavior Problems Checklist-Spanish: a preliminary study of a new scale for the assessment of depressive symptoms and disruptive behaviors in Hispanic patients with dementia. Int Psychogeriatr (2001) 0.75
Apraxia due to a pathologically documented thalamic infarction. Neurology (1994) 0.75
Accurate reading by nonlexical means: a case study. Brain Lang (1987) 0.75
Quantitative evaluation and laboratory studies of topical antibiotic therapy in burns. J Burn Care Rehabil (1987) 0.75
Comparative performance of mildly impaired patients with Alzheimer's disease and multiple cerebral infarctions on tests of memory and functional capacity. Int Psychogeriatr (1994) 0.75
Preserved oral reading in Wernicke's aphasia. Neurology (1983) 0.75
A case of literal alexia: evidence for a disconnection syndrome. Brain Lang (1984) 0.75
General susceptibility in Typhoid and Colon Infection as shown by the Ophthalmic Test. J Med Res (1909) 0.75
Surgical safaris with the East Africa Flying Doctor Service. Arch Surg (1979) 0.75
Additional RFLPs at D10S94 and the development of PCR-based variant detection systems: implications for disease genotype prediction in MEN 2A, MEN 2B, and MTC1 families. Genomics (1992) 0.75
Aminophylline and chronic obstructive pulmonary disease. Ann Intern Med (1988) 0.75
Evaluation of the demented patient. Med Clin North Am (1994) 0.75
Clinicopathologic study of probable Alzheimer disease: assessment of criteria for excluding cerebrovascular disease. Alzheimer Dis Assoc Disord (1995) 0.75
South Florida Program on Aging and Health. Assessing the prevalence of Alzheimer's disease in three ethnic groups. J Fla Med Assoc (1995) 0.75
Aphasia vs functional disorder: factors in differential diagnosis. Psychosomatics (1983) 0.75
Brain biopsy: risks, benefits, and indications. Mt Sinai J Med (1985) 0.75
Family history of dementia and current depression in nondemented community-dwelling older adults. J Geriatr Psychiatry Neurol (2000) 0.75